Search

Your search keyword '"Logeart D"' showing total 456 results

Search Constraints

Start Over You searched for: Author "Logeart D" Remove constraint Author: "Logeart D"
456 results on '"Logeart D"'

Search Results

3. In-hospital prognostic value of TAPSE/sPAP in patients hospitalized for acute heart failure

5. Are the PAH risk stratification tools useful in post-capillary pulmonary hypertension? Insights from the PH-HF study

6. Left atrioventricular coupling index assessed using cardiac CT as a prognostic marker of cardiovascular death

7. Machine learning to predict in-hospital outcomes in patients with acute heart failure

8. Pulmonary hypertension due to left heart disease: First validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

11. Left atrioventricular coupling index assessed using cardiac CT as a prognostic marker of cardiovascular death

12. Machine learning to predict in-hospital outcomes in patients with acute heart failure

15. In-hospital Prognostic Value of TAPSE/sPAP in Patients Hospitalized for Acute Heart Failure

17. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

20. Nouveaux médicaments dans l’insuffisance cardiaque aiguë

25. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

26. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

27. Clinical characteristics and outcomes of worsening heart failure patients with reduced ejection fraction: a French national healthcare database analysis

31. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

32. Serotonin regulates hepcidin expression via a gut-liver axis

33. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

34. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

35. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

36. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

37. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

39. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

40. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

41. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

43. Prognostic value of cardio-pulmonary exercise testing in cardiac amyloidosis

Catalog

Books, media, physical & digital resources